Literature DB >> 17411369

Clinical manifestations associated with HTLV type I infection: a cross-sectional study.

Marina F Caskey1, Daniel J Morgan, Aurelia F Porto, Silvana P Giozza, Andre L Muniz, Glória O Orge, Maria J Travassos, Yolanda Barrón, Edgar M Carvalho, Marshall J Glesby.   

Abstract

Human T-lymphotropic virus type I (HTLV-I) causes HTLV-I-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia in a small percentage of infected individuals. HTLV-I infection is increasingly associated with clinical manifestations. To determine the prevalence of clinical manifestations in HTLV-I infected individuals, we conducted a cross-sectional study of 115 HTLV-I-infected blood donors without myelopathy and 115 age- and sex-matched seronegative controls. Subjects answered a standardized questionnaire and underwent physical examination. Compared with controls, HTLV-I-infected subjects were more likely to report arm or leg weakness (OR = 3.8, 95% CI: 1.4-10.2; OR = 4.0, 95% CI: 1.6-9.8, respectively), hand or foot numbness (OR = 2.1, 95% CI: 1.1-3.9; OR = 4.8, 95% CI: 2.0-11.7, respectively), arthralgia (OR = 3.3, 95% CI: 1.7-6.4), nocturia (OR = 2.7, 95% CI: 1.04-6.8), erectile dysfunction (OR = 4.0, 95% CI: 1.6-9.8), and to have gingivitis (OR = 3.8, 95% CI: 1.8-7.9), periodontitis (OR = 10.0, 95% CI: 2.3-42.8), and dry oral mucosa (OR = 7.5, 95% CI: 1.7-32.8). HTLV-I infection is associated with a variety of clinical manifestations, which may occur in patients who have not developed myelopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17411369      PMCID: PMC2593454          DOI: 10.1089/aid.2006.0140

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  25 in total

1.  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.

Authors:  R C Rosen; J C Cappelleri; M D Smith; J Lipsky; B M Peña
Journal:  Int J Impot Res       Date:  1999-12       Impact factor: 2.896

2.  HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics.

Authors:  Inês Dourado; Luiz C J Alcantara; Maurício L Barreto; Maria da Gloria Teixeira; Bernardo Galvão-Castro
Journal:  J Acquir Immune Defic Syndr       Date:  2003-12-15       Impact factor: 3.731

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Spread and diversity of human populations in Bahia, Brazil.

Authors:  E S Azevêdo; C M Fortuna; K M Silva; M G Sousa; M A Machado; A M Lima; M E Aguiar; K Abé; M C Eulálio; M M Conceição; M C Silva; M G Santos
Journal:  Hum Biol       Date:  1982-05       Impact factor: 0.553

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Authors:  J R Orland; J Engstrom; J Fridey; R A Sacher; J W Smith; C Nass; G Garratty; B Newman; D Smith; B Wang; K Loughlin; E L Murphy
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

7.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.

Authors:  Edward L Murphy; Baoguang Wang; Ronald A Sacher; Joy Fridey; James W Smith; Catharie C Nass; Bruce Newman; Helen E Ownby; George Garratty; Shelia T Hutching; George B Schreiber
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

10.  Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

Authors:  Silvane Braga Santos; Aurélia Fonseca Porto; André Luiz Muniz; Amélia Ribeiro de Jesus; Elza Magalhães; Ailton Melo; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  BMC Infect Dis       Date:  2004-03-02       Impact factor: 3.090

View more
  28 in total

1.  Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.

Authors:  Rosana C P Andrade; José A Neto; Luciana Andrade; Tatiane S Oliveira; Dislene N Santos; Cassius J V Oliveira; Márcio J Prado; Edgar M Carvalho
Journal:  Urology       Date:  2015-12-24       Impact factor: 2.649

2.  Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Authors:  T Luna; S B Santos; M Nascimento; M A F Porto; A L Muniz; E M Carvalho; A R Jesus
Journal:  Braz J Med Biol Res       Date:  2011-10-22       Impact factor: 2.590

3.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

4.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

5.  Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

Authors:  Davi Tanajura; Néviton Castro; Paulo Oliveira; Abraão Neto; André Muniz; Natália B Carvalho; Glória Orge; Silvane Santos; Marshall J Glesby; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

6.  Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder.

Authors:  Paulo Oliveira; Néviton M Castro; André L Muniz; Davi Tanajura; Julio C Brandão; Aurélia F Porto; Edgar M Carvalho
Journal:  Urology       Date:  2010-02-26       Impact factor: 2.649

7.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

8.  Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

Authors:  H H Biswas; J W Engstrom; Z Kaidarova; G Garratty; J W Gibble; B H Newman; J W Smith; A Ziman; J L Fridey; R A Sacher; E L Murphy
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

Review 9.  Viral arthritis.

Authors:  Michael Marks; Jonathan L Marks
Journal:  Clin Med (Lond)       Date:  2016-04       Impact factor: 2.659

Review 10.  Association Between Periodontal Disease and Erectile Dysfunction: A Systematic Review.

Authors:  Sergio Varela Kellesarian; Tammy Varela Kellesarian; Vanessa Ros Malignaggi; Mansour Al-Askar; Alexis Ghanem; Hans Malmstrom; Fawad Javed
Journal:  Am J Mens Health       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.